FDA Inspection
BioMarin Pharmaceutical Inc.BioMarin Pharmaceutical Inc. – FDA Inspection, Nov 6, 2020
Record Details
This FDA Inspection record concerns BioMarin Pharmaceutical Inc., with an inspection on November 6, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BioMarin Pharmaceutical Inc.
- Inspection Date
- November 6, 2020
- Product Type
- Drugs
View Company Profile
ID · 6e2da158-3b88-470e-8a76-7e65e3f46b16
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1133648
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of BioMarin Pharmaceutical Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 7, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 17, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for BioMarin Pharmaceutical Inc.
- FDA Inspection 1119195 - 2020-02-28
- FDA Inspection 1046400 - 2017-12-07
- FDA Inspection 867315 - 2014-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.